How much is a share of Alcon worth?
One share of ALC stock can currently be purchased for approximately $84.82. How much money does Alcon make? Alcon has a market capitalization of $41.41 billion and generates $6.83 billion in revenue each year. The healthcare company earns $-531 million in net income (profit) each year or $0.67 on an earnings per share basis.
Is Alcon close to its 52-week high?
According to the current price, Alcon is 85.03% away from the 52-week high. What are analysts forecasts for Alcon stock? The 28 analysts offering price forecasts for Alcon have a median target of 85.00, with a high estimate of 96.00 and a low estimate of 61.00.
How did Alcon (ALC) perform in the Q1 earnings?
Alcon Inc. (NYSE:ALC) posted its earnings results on Monday, November, 8th. The healthcare company reported $0.54 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.50 by $0.04. The healthcare company earned $2.08 billion during the quarter, compared to analysts' expectations of $2.04 billion.
Should you hold Alcon (ACL) stock?
The consensus among Wall Street analysts is that investors should "hold" Alcon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALC, but not buy additional shares or sell existing shares. View analyst ratings for Alcon or view top-rated stocks.
Should I buy or sell Alcon stock right now?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last year. There are currently 6 hold ratings and 9 buy rati...
What is Alcon's stock price forecast for 2022?
15 Wall Street analysts have issued 12 month price targets for Alcon's shares. Their forecasts range from $68.80 to $96.00. On average, they antici...
How has Alcon's stock performed in 2022?
Alcon's stock was trading at $87.12 at the beginning of 2022. Since then, ALC shares have decreased by 19.6% and is now trading at $70.06. View th...
Are investors shorting Alcon?
Alcon saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 6,670,000 shares, a decline of 23.6% f...
When is Alcon's next earnings date?
Alcon is scheduled to release its next quarterly earnings announcement on Tuesday, August 16th 2022. View our earnings forecast for Alcon .
How were Alcon's earnings last quarter?
Alcon Inc. (NYSE:ALC) released its quarterly earnings data on Tuesday, May, 10th. The healthcare company reported $0.68 earnings per share (EPS) fo...
How often does Alcon pay dividends? What is the dividend yield for Alcon?
Alcon announced a dividend on Saturday, April 23rd. Stockholders of record on Monday, May 2nd will be given a dividend of $0.13 per share on Tuesda...
What guidance has Alcon issued on next quarter's earnings?
Alcon issued an update on its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided earnings per share (EPS) guidance of $2.35-$2.4...
Who are Alcon's key executives?
Alcon's management team includes the following people: Mr. F. Michael Ball , Exec. Chairman (Age 67, Pay $259.82k) Mr. David J. Endicott , CEO...
What is the rating of Alcon?
What is the symbol for Alcon?
Alcon has received a consensus rating of Buy. The company's average rating score is 2.64, and is based on 9 buy ratings, 5 hold ratings, and no sell ratings.
What is Alcon eye care?
Alcon trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALC."
Does Alcon pay dividends?
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices , pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.
Who owns restricted shares of a company?
Alcon does not currently pay a dividend.
When are actual numbers added to the table?
Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
Where is Alcon located?
Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: Kantar Media
What is Alcon eye care?
and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
How many analysts have rated ALC?
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company’s Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Is Alcon Inc. a listed company?
25 Wall Street analysts have issued ratings. Currently, 16 analysts rated ALC as Bullish, 1 rated it Bearish, and 8 rated it Neutral. This suggests a possible increase. View ALC’s analyst predictions. 1 Seeking Alpha authors also rated the stock, and their ratings often outperform those of Wall Street analysts. Here are their ratings on ALC
Is Alcon Inc. on the NYSE?
Alcon Inc. is listed on the NYSE as (NYSE:ALC).
